More than six million Americans are living with Alzheimer’s Disease.
By 2050, that number is projected to be 13 million.
Although there are several drugs to treat the symptoms, there’s only one FDA approved medication to slow the progression.
But now, there’s a new treatment, not a drug, that’s sparking discussion that could slow or halt the progression of this devastating disease.
Andrea Ludema explains more in today’s Healthy Living.